JP2014205707A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014205707A5 JP2014205707A5 JP2014139121A JP2014139121A JP2014205707A5 JP 2014205707 A5 JP2014205707 A5 JP 2014205707A5 JP 2014139121 A JP2014139121 A JP 2014139121A JP 2014139121 A JP2014139121 A JP 2014139121A JP 2014205707 A5 JP2014205707 A5 JP 2014205707A5
- Authority
- JP
- Japan
- Prior art keywords
- ala
- ser
- asp
- thr
- obesity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000008589 Obesity Diseases 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 10
- 235000020824 obesity Nutrition 0.000 claims 8
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 239000013604 expression vector Substances 0.000 claims 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 4
- 206010003210 Arteriosclerosis Diseases 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 208000032928 Dyslipidaemia Diseases 0.000 claims 2
- 208000002705 Glucose Intolerance Diseases 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 206010022489 Insulin Resistance Diseases 0.000 claims 2
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 2
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 2
- 230000000923 atherogenic effect Effects 0.000 claims 2
- 208000012696 congenital leptin deficiency Diseases 0.000 claims 2
- 208000020694 gallbladder disease Diseases 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 208000001022 morbid obesity Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 201000009104 prediabetes syndrome Diseases 0.000 claims 2
- 201000002859 sleep apnea Diseases 0.000 claims 2
- 230000004584 weight gain Effects 0.000 claims 2
- 235000019786 weight gain Nutrition 0.000 claims 2
- 230000004580 weight loss Effects 0.000 claims 2
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 claims 1
- 206010033307 Overweight Diseases 0.000 claims 1
- 101710188315 Protein X Proteins 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229920000642 polymer Chemical group 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014139121A JP5912150B2 (ja) | 2014-07-04 | 2014-07-04 | グルカゴン類似体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014139121A JP5912150B2 (ja) | 2014-07-04 | 2014-07-04 | グルカゴン類似体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011540188A Division JP5635530B2 (ja) | 2008-12-15 | 2008-12-15 | グルカゴン類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014205707A JP2014205707A (ja) | 2014-10-30 |
| JP2014205707A5 true JP2014205707A5 (enrdf_load_stackoverflow) | 2015-01-22 |
| JP5912150B2 JP5912150B2 (ja) | 2016-04-27 |
Family
ID=52119560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014139121A Active JP5912150B2 (ja) | 2014-07-04 | 2014-07-04 | グルカゴン類似体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5912150B2 (enrdf_load_stackoverflow) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2471810A1 (en) * | 2006-02-22 | 2012-07-04 | Merck Sharp & Dohme Corporation | Oxyntomodulin derivatives |
| EP2487184A1 (en) * | 2007-02-15 | 2012-08-15 | Indiana University Research and Technology Corporation | Glucagon/GLP-1 receptor co-agonists |
| US8642540B2 (en) * | 2008-12-15 | 2014-02-04 | Zealand Pharma A/S | Glucagon analogues |
-
2014
- 2014-07-04 JP JP2014139121A patent/JP5912150B2/ja active Active